Vensun Pharmaceuticals
Yardley, US · Founded 2012 · Delaware corporation
Find your way into Vensun Pharmaceuticals
Sign up to see every warm intro you have to Vensun Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vensun Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
HP
Hemanshu PandyaPresident, Chief Executive Officer and Director of Issuer
SE
Syed E. AbidiNamed on SEC filing
Board
DG
Dhananjay G. WadekarBoard director
JW
Jason WildBoard director
ES
Edward SchutterBoard director
KH
Kamlesh HaribhaktiBoard director
Reported raises · per SEC filings
Form D private placements$29.2M disclosed across 3 rounds · 2012–2016
▶$19.5MraisedDec 2016 · 10 investors · PharmaceuticalsRule 506(b)
▶$19.5MraisedDec 2016 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kamlesh HaribhaktiDirector
- Syed E. AbidiDirector
- Michael AltmanDirector
- Hemanshu PandyaExecutive Officer, Director
- Jason WildDirector
- Edward SchutterDirector
- Dhananjay G. WadekarDirector
- Offering amount
- $22.5M
- Amount sold
- $19.5M
- Sales commissions
- $995K
- Proceeds to insiders
- $9K
- Placement agents
- Leerink Partners LLC
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$4MraisedOct 2015 · 15 investors · PharmaceuticalsRule 506(b)
▶$4MraisedOct 2015 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Edward SchutterDirector
- Dhananjay G. WadekarDirector
- Jason WildDirector
- Kamlesh HaribhaktiDirector
- Syed E. AbidiDirector
- Hemanshu PandyaExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $4M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$5.7MraisedMar 2012 · 5 investors · PharmaceuticalsRule 506(b)
▶$5.7MraisedMar 2012 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dhananjay G. WadekarDirector
- Kamlesh HaribhaktiDirector
- Jason WildDirector
- Hemanshu PandyaExecutive Officer, Director
- Syed E. AbidiDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Vensun Pharmaceuticals raised?
- Vensun Pharmaceuticals has disclosed $29.2M raised across 3 rounds.
- Where is Vensun Pharmaceuticals headquartered?
- Vensun Pharmaceuticals is headquartered in Yardley, US.